Bear in mind that ArtemiC is an anti-inflamatory - so used in treatment rather than a cure or a vaccine. Also that 100's of companies are involved and MXC is just one of those.
However, if the formulation can assist then maybe this could be a good break for MXC. God knows, MXC could do with one.
Ann: COVID-19 Clinical Trial Site Expansion into India, page-13
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $13.77M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.5¢ | 29.0¢ | $7.701K | 25.66K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 16444 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 44236 | 1 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| RGT (ASX) Chart |